SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Widimsky Petr) srt2:(2005-2009)"

Sökning: WFRF:(Widimsky Petr) > (2005-2009)

  • Resultat 1-10 av 13
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Graham, Ian, et al. (författare)
  • European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
  • 2007
  • Ingår i: European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. - : Oxford University Press (OUP). - 1741-8267. ; 14 Suppl 2, s. S1-113
  • Tidskriftsartikel (refereegranskat)abstract
    • Other experts who contributed to parts of the guidelines: Edmond Walma, Tony Fitzgerald, Marie Therese Cooney, Alexandra Dudina European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG): Alec Vahanian (Chairperson), John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Christian Funck-Brentano, Gerasimos Filippatos, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, Jose Luis Zamorano Document reviewers: Irene Hellemans (CPG Review Co-ordinator), Attila Altiner, Enzo Bonora, Paul N. Durrington, Robert Fagard, Simona Giampaoli, Harry Hemingway, Jan Hakansson, Sverre Erik Kjeldsen, Mogens Lytken Larsen, Giuseppe Mancia, Athanasios J. Manolis, Kristina Orth-Gomer, Terje Pedersen, Mike Rayner, Lars Ryden, Mario Sammut, Neil Schneiderman, Anton F. Stalenhoef, Lale Tokgözoglu, Olov Wiklund, Antonis Zampelas
  •  
3.
  • Harrington, Robert A., et al. (författare)
  • The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial : study design and rationale
  • 2009
  • Ingår i: American Heart Journal. - : Elsevier BV. - 0002-8703 .- 1097-6744. ; 158:3, s. 327-334
  • Tidskriftsartikel (refereegranskat)abstract
    • Background The protease-activated receptor 1 (PAR-1), the main platelet receptor for thrombin, represents a novel target for treatment of arterial thrombosis, and SCH 530348 is an orally active, selective, competitive PAR-1 antagonist. We designed TRA.CER to evaluate the efficacy and safety of SCH 530348 compared with placebo in addition to standard of care in patients with non-ST-segment elevation (NSTE) acute coronary syndromes (ACS) and high-risk features. Trial design TRA.CER is a prospective, randomized, double-blind, multicenter, phase III trial with an original estimated sample size of 10,000 subjects. Our primary objective is to demonstrate that SCH 530348 in addition to standard of care will reduce the incidence of the composite of cardiovascular death, myocardial infarction (MI), stroke, recurrent ischemia with rehospitalization, and urgent coronary revascularization compared with standard of care alone. Our key secondary objective is to determine whether SCH 530348 will reduce the composite of cardiovascular death, MI, or stroke compared with standard of care alone. Secondary objectives related to safety are the composite of moderate and severe GUSTO bleeding and clinically significant TIMI bleeding. The trial will continue until a predetermined minimum number of centrally adjudicated primary and key secondary end point events have occurred and all subjects have participated in the study for at least I year. The TRA.CER trial is part of the large phase III SCH 530348 development program that includes a concomitant evaluation in secondary prevention. Conclusion TRA.CER will define efficacy and safety of the novel platelet PAR-1 inhibitor SCH 530348 in the treatment of high-risk patients with NSTE ACS in the setting of current treatment strategies.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 13
Typ av publikation
tidskriftsartikel (13)
Typ av innehåll
refereegranskat (12)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Widimsky, Petr (13)
Zamorano, Jose Luis (12)
Tendera, Michal (11)
Dean, Veronica (11)
Filippatos, Gerasimo ... (11)
De Caterina, Raffael ... (11)
visa fler...
Dickstein, Kenneth (11)
Silber, Sigmund (11)
Sechtem, Udo (11)
Funck-Brentano, Chri ... (11)
Vahanian, Alec (11)
McGregor, Keith (11)
Hellemans, Irene (11)
Camm, John (10)
Kristensen, Steen Da ... (8)
Priori, Silvia G (7)
Blomström-Lundqvist, ... (5)
De Backer, Guy (5)
Fagard, Robert (5)
Cifkova, Renata (5)
Ruilope, Luis (5)
Linde, Cecilia (4)
Drexler, Helmut (4)
Auricchio, Angelo (4)
Gasparini, Maurizio (4)
Vardas, Panos E (4)
Blanc, Jean-Jacques (4)
Oto, Ali (4)
Brignole, Michele (4)
Cleland, John (4)
Sutton, Richard (4)
Mancia, Giuseppe (4)
Le Heuzey, Jean-Yves (4)
Daubert, Jean-Claude (4)
Manolis, Athanasios ... (4)
Ritter, Philippe (4)
Nilsson, Peter M (3)
Laurent, Stephane (3)
Lip, Gregory Y H (3)
Lindholm, Lars H (3)
Viigimaa, Margus (3)
Redon, Josep (3)
Narkiewicz, Krzyszto ... (3)
Grassi, Guido (3)
Kjeldsen, Sverre E. (3)
Schmieder, Roland E. (3)
Dalby Kristensen, St ... (3)
Dominiczak, Anna (3)
Zanchetti, Alberto (3)
Rynkiewicz, Andrzej (3)
visa färre...
Lärosäte
Uppsala universitet (8)
Göteborgs universitet (4)
Umeå universitet (3)
Lunds universitet (1)
Språk
Engelska (10)
Italienska (1)
Polska (1)
Portugisiska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy